CSL Biotherapies Files Flu Vaccine BLA
This article was originally published in The Pink Sheet Daily
Firm is requesting an expedited review in order to have vaccine available for 2007-2008 flu season, company tells “The Pink Sheet” DAILY.
You may also be interested in...
ZLB Behring is falsely promoting an unapproved indication for the immune globulin product in an American Hospital Formulary Service fact sheet, FDA says.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.